Entero Therapeutics, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sarepta Obtains Rights To Seven Arrowh

Lykos Therapeutics , still reeling from US Food and Drug Administration rejection of the company’s capsule formulation of the psychedelic drug midomafetamine for the treatment of post-traumatic stress

Recently troubled First Wave BioPharma, Inc. is adding pipeline and clinical development capability in an all-stock merger with privately held ImmunogenX , a deal announced on 18 December that will

First Wave BioPharma, Inc. has had to navigate some choppy waters in the past few months but the US firm has pulled off something of a coup by bagging the rights to an old Sanofi compound for peanu